NEXGEL, Inc. Announces Intention of Miranda J. Toledano to Resign as a Member of the Board of Directors, Effective as of March 31, 2024
January 16, 2024 at 04:30 pm EST
Share
On January 9, 2024, Miranda J. Toledano notified NexGel, Inc. of her intent to resign as a member of the Company?s Board of Directors (the ?Board?) effective as of March 31, 2024. Ms. Toledano is the Chairperson of the Board?s Audit Committee and a member of Nominating and Corporate Governance Committee. The Company intends to replace Mr. Toledano on both the Audit Committee and the Nominating and Corporate Governance Committee with other members of the Board who qualify as ?independent?
NexGel, Inc. is a provider of ultra-gentle, high-water-content hydrogels for healthcare and consumer applications. It is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics. It specializes in custom gels by capitalizing on proprietary manufacturing technologies. Its gels and its consumer products are manufactured using proprietary and non-proprietary mixing, coating, and crosslinking technologies. It markets under the brand names MedaGel and LumaGel Beauty. The products it sells under its MedaGel brand primarily relate to over the counter (OTC) remedy solutions, such as blister and pain applications; while the products it sells under its LumaGel Beauty brand primarily relate to beauty and cosmetic solutions, such as wrinkle and skin cream applications. The Company is also engaged in treating the symptoms of Psoriasis through its brand Kenkoderm.
NEXGEL, INC. 
